That approach includes increased usage of prevention and treatment programs and lifesaving overdose avoidance medications like naloxone, enhanced education for physicians and sufferers and modernized and funded prescription drug monitoring programs fully.. PRESS RELEASE CHICAGO –The American Medical Association has joined with organizations representing physicians, pharmacists, supply chains and other stakeholder groups to develop aconsensus documenthighlighting the red flag warning signs of prescription substance abuse and diversion.Quinet, MD, FACP, Ochsner Health Program Rami Rihani, PharmD, Advocate Medical Group ‘In today's health care environment, quality outcomes in specialty caution, including rheumatology, will increasingly have an effect on provider organizations' important thing,’ stated Donald W. Fisher, Ph.D., CAE, president and ceo of the American Medical Group Association and secretary of the plank of AMGF. ‘Participation in the AMGF Best Practices RA Collaborative gives participants mission-critical knowledge in engaging specialty departments such as for example rheumatology in performance measurement and improvement.’ The program presents a shared learning environment where participants can exchange strategies and experiences as they work to boost the care provided to sufferers with RA.